MedPath

BOTOX

BOTOX

Approved
DIN Number

02531585

Drug Class

Human

Market Date

Oct 11, 2023

Company
HC

Abbvie Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02531585
AIG Number0151557004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
M03AX01 BOTULINUM TOXIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular
AHFS Classification12:20.20.24
Health Canada Classification

ACTIVE INGREDIENTS (1)

ONABOTULINUMTOXINAActive
Strength: 200 UNIT / VIAL
Monograph: ONABOTULINUMTOXINA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.